Tentang Jurnal Ini
Journal of Collaborative Biomedicine is an open-access, peer-reviewed scientific journal dedicated to advancing biomedical knowledge through collaborative, interdisciplinary, and translational research. The journal provides a scholarly platform for researchers, clinicians, academics, and health professionals to disseminate high-quality scientific work in biomedical sciences, molecular medicine, clinical research, preventive medicine, and health innovation.
As a journal under the Medical Study Program, Faculty of Medicine, Universitas Negeri Surabaya, the Journal of Collaborative Biomedicine emphasizes the integration of biomolecular sciences, clinical medicine, public health, and applied biomedical research. The journal particularly encourages studies that contribute to the improvement of health outcomes, disease prevention, diagnostic development, therapeutic innovation, and evidence-based medical practice.
In line with the global commitment to sustainable development, the journal supports research that contributes to the Sustainable Development Goals (SDGs), particularly SDG 3: Good Health and Well-being, SDG 4: Quality Education, SDG 9: Industry, Innovation and Infrastructure, and SDG 17: Partnerships for the Goals. Through this orientation, the journal seeks to promote biomedical research that is scientifically rigorous, socially relevant, and capable of supporting collaborative solutions for current and future health challenges.
The journal welcomes original research articles, review articles, systematic reviews, case reports, short communications, and other scholarly contributions that advance biomedical understanding and its application in diagnostics, therapeutics, prevention, rehabilitation, and health promotion.
AIM AND SCOPE
The Journal of Collaborative Biomedicine aims to promote integrative and collaborative research in biomedical sciences and medicine. The journal seeks to bridge basic biomedical research, clinical application, preventive health, and interdisciplinary innovation.
The scope of the journal includes, but is not limited to, the following areas:
- Biomolecular and Biomedical Sciences: The journal welcomes studies exploring molecular mechanism underlying health and disease, Including:
- Genetics, genomics, and epigenetics
- Proteomics, metabolomics, and other omics-based research
- Molecular biomarkers for diagnosis, prognosis, and therapeutic response
- Pathophysiological mechanisms of communicable and non-communicable diseases
- Molecular basis of inflammation, oxidative stress, aging, and metabolic disorders
- Experimental biomedical research using in vitro, in vivo, or translational models
- Cellular and Immunology Analysis: The journal supports research focusing on cellular mechanisms and immune responses, including:
- Cellular microenvironment and intercellular communication
- Immunological mechanisms in infectious, inflammatory, autoimmune, metabolic, and degenerative diseases
- Stem cell biology and regenerative medicine
- Cell-based therapy and tissue repair
- Cancer cell biology and tumor microenvironment
- Host-pathogen interaction and immune modulation
- Clinical Applications: The journal encourages research that connects biomedical findings with clinical relevance, including:
- Diagnostic innovation and laboratory medicine
- Molecular diagnostics, PCR-based methods, sequencing, and biomarker validation
- Personalized and precision medicine
- Gene therapy, cell-based therapy, and targeted therapy
- Clinical epidemiology and evidence-based medicine
- Clinical case reports with biomedical or educational significance
- Preventive Medicine, Public Health, and Health Promotion: The journal welcomes biomedical and clinical studies related to disease prevention and health improvement, including:
- Preventive strategies for communicable and non-communicable diseases
- Risk factor analysis and early detection
- Community-based biomedical and medical research
- Health behavior, lifestyle medicine, and preventive interventions
- Epidemiological studies with clinical or biomedical relevance
- Health education and medical education related to biomedical practice
- Sport and Exercise Medicine: In accordance with the academic strength and institutional direction of the Faculty of Medicine, Universitas Negeri Surabaya, the journal particularly encourages research related to sports and exercise medicine, including:
- Exercise physiology and biomedical adaptation to physical activity
- Sports injury, rehabilitation, and musculoskeletal health
- Biomarkers related to physical performance, fatigue, inflammation, and recovery
- Exercise intervention in metabolic, cardiovascular, respiratory, and degenerative diseases
- Athlete health, performance, and preventive medicine
- Translational research in sports medicine and health optimization
- Biomedical Innovation and Interdisciplinary Collaboration : The journal also supports interdisciplinary research involving biomedical science and health innovation, including:
- Biomedical technology and diagnostic development
- Artificial intelligence and digital health applications in biomedical research
- Medical devices, biosensors, and laboratory innovation
- Collaborative research between medicine, biology, engineering, data science, public health, and allied health sciences
- Research partnerships that support sustainable health development
Through this scope, the Journal of Collaborative Biomedicine aims to foster meaningful collaboration among researchers, clinicians, educators, health professionals, and industry partners in order to strengthen biomedical science and improve health outcomes.
OPEN ACCESS POLICY
The Journal of Collaborative Biomedicine provides immediate open access to its published content. All articles are freely available to readers worldwide without subscription or access barriers.
COPYRIGHT NOTICE
Authors retain the copyright of their published work and grant the Journal of Collaborative Biomedicine the right of first publication.
All published articles are licensed under a Creative Commons Attribution License (CC BY), which permits others to read, download, copy, distribute, print, search, link to, adapt, and use the work for any lawful purpose, provided that appropriate credit is given to the original author(s) and the journal.
This licensing policy supports open science, responsible knowledge sharing, and broader dissemination of biomedical research.
SPONSORHIP AND FUNDING
The Journal of Collaborative Biomedicine is published under the academic management of the Medical Study Program, Faculty of Medicine, Universitas Negeri Surabaya.
PRIVACY STATMENT
The Journal of Collaborative Biomedicine ensures the long-term preservation of its content through inclusion in the LOCKSS (Lots of Copies Keep Stuff Safe) and CLOCKSS (Controlled Lots of Copies Keep Stuff Safe) archival systems. These systems guarantee that published articles remain accessible even in the event of catastrophic data loss or discontinuation of the journal.
HISTORY OF THE JOURNAL
The Journal of Collaborative Biomedicine was established by the Medical Study Program, Faculty of Medicine, Universitas Negeri Surabaya, as part of its commitment to strengthening biomedical research, academic publication, and scientific collaboration.
The journal was developed to provide an academic platform for the dissemination of research in biomedical sciences, clinical medicine, preventive health, sports and exercise medicine, and interdisciplinary health innovation. Its establishment reflects the need for a collaborative scientific space that connects basic biomedical research with clinical and community applications.
As a developing academic journal, the Journal of Collaborative Biomedicine is committed to promoting scientific quality, publication ethics, open access, and research collaboration at national and international levels. The journal aims to contribute to the advancement of biomedical science and to support research aligned with global health priorities and the Sustainable Development Goals.
PUBLICATION ETHICS AND MALPRACTICES STATMENT
The Journal of Collaborative Biomedicine is committed to upholding the highest standards of publication ethics and academic integrity. All parties involved in the publication process, including authors, editors, reviewers, and the publisher, are expected to follow ethical principles in scholarly publishing.
The journal does not tolerate plagiarism, data fabrication, data falsification, duplicate publication, inappropriate authorship, undisclosed conflicts of interest, or other forms of publication misconduct.
Manuscripts submitted to the journal must be original, scientifically valid, and not under consideration by other journals. Authors are responsible for ensuring that their work complies with ethical standards, including ethical approval for studies involving human participants, animals, biological specimens, or sensitive data when applicable.
The editorial team reserves the right to reject or retract manuscripts that violate ethical standards.
PEER REVIEW PROCESS
All manuscripts submitted to the Journal of Collaborative Biomedicine undergo an initial editorial screening to assess their relevance to the journal’s scope, scientific quality, originality, ethical compliance, and adherence to author guidelines.
Manuscripts that pass the initial screening are sent for peer review by qualified reviewers with relevant expertise. The journal applies a peer-review process to ensure the academic quality, validity, and contribution of each published article.
The final decision regarding manuscript acceptance, revision, or rejection is made by the editorial team based on reviewers’ recommendations, scientific merit, ethical considerations, and relevance to the journal’s aims and scope.
AUTHOR GUIDELINES- BRIEF DESCRIPTION
The Journal of Collaborative Biomedicine accepts manuscripts in the form of original research articles, review articles, systematic reviews, case reports, short communications, and other scholarly works within the journal’s scope.
Authors are expected to prepare manuscripts according to the journal’s template and submission guidelines. Manuscripts must be written clearly, ethically, and scientifically, with appropriate citations, valid methodology, and transparent reporting of findings.
Studies involving human participants, animals, or biological samples must include a statement of ethical approval where applicable.
CALL FOR SUBMISSIONS
The Journal of Collaborative Biomedicine invites researchers, clinicians, academics, health professionals, and scholars to submit manuscripts that contribute to the advancement of biomedical sciences and medical knowledge.
The journal welcomes collaborative and interdisciplinary works that address current health challenges, promote biomedical innovation, and support sustainable health development.
Submissions related to molecular medicine, clinical research, preventive medicine, sports and exercise medicine, translational biomedicine, public health, medical education, and health innovation are particularly encouraged.
